✦ LIBER ✦
Salvage treatment for primary resistant acute myelogenous leukemia consisting of intermediate-dose cytosine arabinoside and interspaced continuous infusions of idarubicin: A phase-II study (no. 06901) of the EORTC Leukemia Cooperative Group
✍ Scribed by T. De Witte; S. Suciu; D. Selleslag; B. Labar; K. Roozendaal; R. Zittoun; M. Ribeiro; R. Kurstjens; M. Hayat; M. Dardenne; G. Solbu; P. Muus
- Publisher
- Springer
- Year
- 1996
- Tongue
- English
- Weight
- 156 KB
- Volume
- 72
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.